Identification Properties Safety Data Specifications & Other Information Links Identification CAS Number 7081-53-0
Name Doxapram HCl
Synonyms 1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone hydrochloride hydrate 1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone monohydrochloride monohydrate 1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone hydrochloride hydrate [
ACD /
IUPAC Name] 1-Éthyl-4-[2-(4-morpholinyl)éthyl]-3,3-diphényl-2-pyrrolidinone, chlorhydrate, hydrate [French] [
ACD /
IUPAC Name] 1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinonhydrochloridhydrat [German] [
ACD /
IUPAC Name] 1-Ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrochloride hydrate 204-022-3 [
EINECS ] 2-Pyrrolidinone, 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-, hydrochloride, hydrate (1:1:1) [
ACD /Index Name] 7081-53-0 [
RN ] Dopram [Trade name] [Wiki] Doxapram Hydrochloride Doxapram Hydrochloride hydrate Doxapram monohydrochloride monohydrate
P5RU6UOQ5Y Stimulexin
UNII :
P5RU6UOQ5Y (±)-doxapram hydrochloride monohydrate [7081-53-0] 113-07-5 [
RN ] 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one and hydron and chloride and hydrate 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one;hydrate;hydrochloride 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one;hydron;chloride;hydrate 1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-Pyrrolidinone, monohydrochloride, monohydrate(
8CI ) 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-pyrrolidin-2-one 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-pyrrolidin-2-one hydrate hydrochloride 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one monohydrochloride 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone hydrate hydrochloride 1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone, hydrochloride, hydrate(1:1:1) 1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-Pyrrolidinone, monohydrochloride, monohydrate (
9CI ) 1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrate hydrochloride 1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrochloride monohydrate 1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrochloride – water (1/1) 2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride, monohydrate 2-Pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, monohydrochloride, monohydrate 2-Pyrrolidinone, 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-, monohydrochloride, monohydrate 4-[2-(1-ethyl-5-oxo-4,4-diphenylpyrrolidin-3-yl)ethyl]morpholin-4-ium chloride – water (1/1) Dopram hydrochloride hydrate Dopram hydrochloride hydrate;Stimulex hydrochloride hydrate;Respiram hydrochloride hydrate Doxapram (hydrochloride hydrate)
DOXAPRAM HCL Doxapram hydrochloride monohydrate Doxapram Hydrochloride Monohydrate 1.0 mg/ml in Methanol (as anhydrous free base) hydrate Hydrochloride
HYDROGEN DOXAPRAM HYDRATE CHLORIDE MFCD09954698 Respiram hydrochloride hydrate Stimulex hydrochloride hydrate
SMILES CCN1CC (C(
C1 =O)(c2ccccc2)c3ccccc3)
CCN4CCOCC4 .O.Cl
StdInChI InChI=
1S /
C24H30N2O2 .ClH.
H2O /c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21;;/h3-12,
22H ,2,13-19H2,
1H3 ;
1H ;
1H2 StdInChIKey ZOMBFZRWMLIDPX-UHFFFAOYSA-N Molecular Formula C24H30N2O2 .HCl.
H2O Molecular Weight 432.99
Properties Appearance White to off-white crystalline powder
Melting Point Around 220℃
Safety Data Symbol GHS06 Signal Word Danger
Hazard Statements H301 Precautionary Statements Missing Phrase – N15 .00950417 RIDADR UN 2811 6.1 /
PGIII WGK Germany 3
Specifications and Other Information of Our Doxapram HCl CAS 7081-53-0 Standard USP38 Identification Methods IR ,
UV Assay 98.0%~100.5%
Heavy Metals ≤20ppm
pH 3.5~5.0
Loss on Drying 3.0%~4.5%
Residue on Ignition ≤0.3%
Organic Impurities ≤0.2%
Package According to customer requirements to packaging
Storage Under the room temperature and away from light
Application It is commonly used for respiratory depression caused by central inhibitory drugs, acute respiratory failure,
COPD complicated with acute respiratory failure, and accelerated wake-up after anesthesia.
Links This product is developed by our R
& D company Caming Pharmaceutical Ltd(
http://www.caming.com/ ), and here is the corresponding link
http://www.caming.com/doxapram-hcl-cas-7081-53-0/ Quick Inquiry Fill out our inquiry form and one of our experts will be in touch with you shortly (Please change screen to horizontal for complete browsing if you are checking Watson on your mobile phone).
Identification Properties Safety Data Specifications & Other Information Links
GHS06
